Skip to main content
. 2021 Feb 9;235:12–23. doi: 10.1016/j.ahj.2021.02.001

Figure 4.

Figure 4

Study start-up timeline in PREVENT-HD. To respond to the public health crisis presented by COVID-19, study start-up timelines for PREVENT-HD were accelerated. From first draft of the protocol to first participant enrolled required only 127 days. FDA, Food and Drug Administration; FPI, first participant in; IRB, Institutional Review Board; IND, Investigational New Drug; SA, site activation.